Bank of New York Mellon Corp - SPRINGWORKS THERAPEUTICS INC ownership

SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 142 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of SPRINGWORKS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,031,484
-12.9%
217,625
-1.2%
0.00%0.0%
Q2 2023$5,776,339
+76.5%
220,303
+73.2%
0.00%0.0%
Q1 2023$3,273,094
-0.1%
127,160
+1.0%
0.00%0.0%
Q4 2022$3,275,127
-23.7%
125,918
-16.3%
0.00%0.0%
Q3 2022$4,293,000
+36.5%
150,454
+17.8%
0.00%0.0%
Q2 2022$3,145,000
-52.2%
127,721
+9.6%
0.00%0.0%
Q1 2022$6,576,000
-9.4%
116,523
-0.5%
0.00%0.0%
Q4 2021$7,260,000
-1.7%
117,125
+0.7%
0.00%0.0%
Q3 2021$7,382,000
-17.8%
116,356
+6.8%
0.00%
-50.0%
Q2 2021$8,983,000
+35.7%
108,996
+21.1%
0.00%
+100.0%
Q1 2021$6,620,000
-0.9%
89,990
-2.3%
0.00%0.0%
Q4 2020$6,679,000
+85.5%
92,092
+22.0%
0.00%0.0%
Q3 2020$3,600,000
+14.3%
75,510
+0.7%
0.00%0.0%
Q2 2020$3,149,000
+197.1%
74,980
+91.0%
0.00%
Q1 2020$1,060,000
+5.6%
39,260
+50.5%
0.00%
Q4 2019$1,004,00026,0810.00%
Other shareholders
SPRINGWORKS THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 3,081,307$71,239,8187.97%
Finepoint Capital LP 556,928$12,876,1756.41%
M28 Capital Management LP 197,700$4,570,8245.24%
Boxer Capital, LLC 3,421,541$79,106,0284.21%
Deep Track Capital, LP 3,546,435$81,993,5773.16%
EcoR1 Capital, LLC 3,460,208$80,000,0092.70%
Orbimed Advisors 3,968,588$91,753,7551.95%
Artal Group S.A. 1,816,620$42,0001.80%
SPHERA FUNDS MANAGEMENT LTD. 319,911$7,396,3421.35%
Perceptive Advisors 1,520,416$35,152,0171.17%
View complete list of SPRINGWORKS THERAPEUTICS INC shareholders